Christopher Sanchez, MD
Orthopaedic Surgery · Lacombe, LANPI 1558656025
Payments from drug & device makers
Across 78 payments — averaging $18.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$201
- Smith+Nephew$136
- Stryker$123
- Pacira Therapeutics, Inc.$106
- Grifols USA, LLC$105
- Biocomposites Inc$63
- plus $710 from 26 others
What the payments were for
- Food & beverage$1,443100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 17 | $201 |
| Smith+Nephew | 3 | $136 |
| Stryker | 5 | $123 |
| Pacira Therapeutics, Inc. | 6 | $106 |
| Grifols USA, LLC | 6 | $105 |
| Biocomposites Inc | 2 | $63 |
| Pacira Pharmaceuticals Incorporated | 4 | $58 |
| Zimmer Biomet | 1 | $51 |
| AbbVie | 3 | $46 |
| Vertex | 3 | $45 |
| CSL Behring | 2 | $44 |
| Kyowa Kirin, Inc. | 2 | $40 |
| Paratek Pharmaceuticals, Inc. | 2 | $39 |
| Upsher-smith Laboratories LLC | 2 | $32 |
| Dynasplint Systems Inc. | 2 | $31 |
| Sonex Health, Inc. | 2 | $28 |
| Avanos Medical | 1 | $27 |
| SPR Therapeutics, Inc | 1 | $24 |
| Biotissue Holdings Inc. | 1 | $22 |
| Sanara Medtech Inc. | 1 | $22 |
| Lundbeck LLC | 1 | $21 |
| Neurocrine Biosciences, Inc. | 1 | $20 |
| GRT US Holding, Inc. | 1 | $20 |
| Vericel Corporation | 1 | $18 |
| Sentynl Therapeutics, Inc. | 1 | $17 |
| Baudax Bio Inc. | 1 | $17 |
| Ferring Pharmaceuticals Inc. | 1 | $17 |
| IBSA Pharma Inc. | 1 | $16 |
| Johnson & Johnson | 1 | $16 |
| Convatec Inc. | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $13 |
| ERMI LLC | 1 | $11 |
How this compares
$1,443 in reported general payments places this provider in the 35th percentile of 286 orthopaedic surgery providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 79 | $1,410 |
| Meloxicam | 231 | $720 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 56 | $656 |
| Tramadol Hcl | 23 | $152 |
| Methylprednisolone | 12 | $79 |
| Amoxicillin | 28 | $36 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Lacombe
- Pierce NunleyShreveport$3.8M
- Christopher HarrodBaton Rouge$3.1M
- Vinod DasaKenner$1.9M
- Jorge IsazaBaton Rouge$1.2M
- Robert ZuraNew Orleans$792K
- Kevin McCarthyBaton Rouge$714K
- Fernando SanchezNew Orleans$655K
- Neil MakiThibodaux$620K
- Timmothy RandellAlexandria$498K
- Robert EastonBaton Rouge$394K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.